InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
0.00%
)
US TECH 100
19,205.20
(
0.21%
)
Dow Jones
39,118.86
(
0.00%
)
Brent Oil
85.54
(
0.50%
)
Bitcoin
62,854.73
(
0.41%
)
Post# of 252444
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119956
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Thursday, 12/27/2012 7:44:51 PM

Thursday, December 27, 2012 7:44:51 PM

Post# of 252444
Teva dumps Proteologics collaboration:

http://www.globes.co.il/serveen/globes/docview.asp?did=1000809779&fid=1725

Teva Pharmaceutical Industries Ltd. today notified Proteologics Ltd. (TASE: PRTL) that it was terminating the licensing agreement to develop several molecules on which the two companies were collaborating.

…Proteologics is a drug development company which focuses primarily on discovering inhibitors for specific E3 ubiquitin ligases for targeted therapies for cancer and inflammatory diseases. The termination is part of Teva's new strategic plan.

The collaboration was inked in May 2005 (#msg-6218593).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up